Stock Track | Organon & Co Plunges 8.84% in Pre-Market After Q4 Earnings Miss Estimates

Stock Track

Feb 12

Organon & Co's stock experienced a significant pre-market plunge of 8.84% on Thursday. The sharp decline occurred as the market reacted to the company's latest financial results.

The sell-off was triggered by the release of Organon's fourth-quarter earnings, which fell short of analyst expectations. The company reported an adjusted EPS of $0.63, missing the IBES estimate of $0.73. Furthermore, Q4 revenue came in at $1,507 million, below the estimated $1,539 million. The company also posted a net loss of $205 million, or a loss of $0.79 per share, for the quarter.

Other reported metrics included an adjusted EBITDA margin of 25.4%, a gross margin of 49.2%, and an adjusted net income of $165 million, which also fell short of the $192.6 million estimate. The company provided a full-year revenue outlook of $1,900 million. The widespread misses on key financial targets likely led to investor disappointment and the subsequent pre-market downturn.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1181919746"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181919746\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181919746?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-12 20:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181919746","market":"nz","top_or_hot":-1,"title":"Stock Track | Organon & Co Plunges 8.84% in Pre-Market After Q4 Earnings Miss Estimates","media":"Stock Track","content":"<p>Organon & Co's stock experienced a significant pre-market plunge of 8.84% on Thursday. The sharp decline occurred as the market reacted to the company's latest financial results.</p><p>The sell-off was triggered by the release of Organon's fourth-quarter earnings, which fell short of analyst expectations. The company reported an adjusted EPS of $0.63, missing the IBES estimate of $0.73. Furthermore, Q4 revenue came in at $1,507 million, below the estimated $1,539 million. The company also posted a net loss of $205 million, or a loss of $0.79 per share, for the quarter.</p><p>Other reported metrics included an adjusted EBITDA margin of 25.4%, a gross margin of 49.2%, and an adjusted net income of $165 million, which also fell short of the $192.6 million estimate. The company provided a full-year revenue outlook of $1,900 million. The widespread misses on key financial targets likely led to investor disappointment and the subsequent pre-market downturn.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Organon & Co Plunges 8.84% in Pre-Market After Q4 Earnings Miss Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Organon & Co Plunges 8.84% in Pre-Market After Q4 Earnings Miss Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-12 20:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Organon & Co's stock experienced a significant pre-market plunge of 8.84% on Thursday. The sharp decline occurred as the market reacted to the company's latest financial results.</p><p>The sell-off was triggered by the release of Organon's fourth-quarter earnings, which fell short of analyst expectations. The company reported an adjusted EPS of $0.63, missing the IBES estimate of $0.73. Furthermore, Q4 revenue came in at $1,507 million, below the estimated $1,539 million. The company also posted a net loss of $205 million, or a loss of $0.79 per share, for the quarter.</p><p>Other reported metrics included an adjusted EBITDA margin of 25.4%, a gross margin of 49.2%, and an adjusted net income of $165 million, which also fell short of the $192.6 million estimate. The company provided a full-year revenue outlook of $1,900 million. The widespread misses on key financial targets likely led to investor disappointment and the subsequent pre-market downturn.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OGN","symbol_name":"Organon & Co","start_time":0,"source_url":"","article_id":"1181919746","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181919746","pubTimestamp":1770899558,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Organon & Co's stock experienced a significant pre-market plunge of 8.84% on Thursday. The sharp decline occurred as the market reacted to the company's latest financial results.The sell-off was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OGN":"Organon & Co"},"translate_title":"股票追踪|第四季度盈利未达预期Organon&Co盘前暴跌8.84%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OGN":1},"content_text":"Organon & Co's stock experienced a significant pre-market plunge of 8.84% on Thursday. The sharp decline occurred as the market reacted to the company's latest financial results.The sell-off was triggered by the release of Organon's fourth-quarter earnings, which fell short of analyst expectations. The company reported an adjusted EPS of $0.63, missing the IBES estimate of $0.73. Furthermore, Q4 revenue came in at $1,507 million, below the estimated $1,539 million. The company also posted a net loss of $205 million, or a loss of $0.79 per share, for the quarter.Other reported metrics included an adjusted EBITDA margin of 25.4%, a gross margin of 49.2%, and an adjusted net income of $165 million, which also fell short of the $192.6 million estimate. The company provided a full-year revenue outlook of $1,900 million. The widespread misses on key financial targets likely led to investor disappointment and the subsequent pre-market downturn.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}